findmyKOL
Clinical trialNCT00403546CompletedPhase 3Interventional

High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia Symptoms

SponsorDonald C. Goff, MDEnrollment131Schizophrenia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Medical College of Georgia

    Augusta, Georgia, United States

  • Corrigan Mental Health Center

    Fall River, Massachusetts, United States

  • Touchstone Innovare

    Grand Rapids, Michigan, United States

  • University of New Mexico

    Albuquerque, New Mexico, United States

  • Suny Downstate Medical Center

    Brooklyn, New York, United States

  • the Lieber Center for Schizophrenia Research - Columbia University

    New York, New York, United States

  • Nathan Kline Institute

    Orangeburg, New York, United States

  • Duke University - John Umstead Hospital

    Butner, North Carolina, United States

  • the Mech Center

    Plano, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2006
Primary completion
31 May 2011
Completion
31 May 2011
Last update posted
6 Jun 2017
Registered enrollment
131
Registry id
NCT00403546

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.